Similarly, the correlation of the nodule growth rate and the expression of GD2 (commonly considered a marker of NB aggressiveness) is remarkably lower than that of MCM2 and CA9 on the same parameter, thus suggesting the use of these novel markers in the determination of the aggressiveness in NB nodules from patients. The gene discussed is CA9; the disease is neuroblastoma.